Mechanism of ZCCHC6 Regulation of Mitochondrial Dysfunction In Alzheimer's Disease
ZCCHC6调节阿尔茨海默病线粒体功能障碍的机制
基本信息
- 批准号:10358830
- 负责人:
- 金额:$ 75.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-01 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:3&apos Untranslated Regions3xTg-AD mouseAPP-PS1AffectAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease brainAlzheimer&aposs disease modelAmericanAmyloid depositionBiologicalBrainBreedingCell DeathCellsConfocal MicroscopyDataDefectDegenerative polyarthritisDevelopmentDiseaseDynaminEnzymesEventFibrinogenFunctional disorderGene ExpressionGene Expression ProfileGenesGenetic TranscriptionGenetic TranslationGoalsHippocampus (Brain)HumanImmunofluorescence ImmunologicImpaired cognitionImpairmentIn VitroKnockout MiceLiteratureMediatingMembrane PotentialsMethodsMicroRNAsMitochondriaMitochondrial Membrane ProteinMolecularMouse StrainsMusNeurodegenerative DisordersNeurofibrillary TanglesNeuronsNucleotidesOrganellesOxidative StressPathogenesisPathologicPatientsPlasmidsPlayPre-Clinical ModelPreventiveProductionProteinsRNAReactive Oxygen SpeciesRegulationReporterReportingResearchRisk FactorsRoleSenile PlaquesSmall Interfering RNAStressStructureSurfaceTailTestingTherapeuticTissue BanksTransferaseUp-Regulationagedbrain tissueclinically relevantcognitive functiondesigngene repressionhuman diseasein vivomRNA ExpressionmiRNA expression profilingmitochondrial dysfunctionmitochondrial membranemouse modelmutantneuron lossneuropathologynovelprecision medicinepreventrecruitspatiotemporaltissue degenerationtransgenic model of alzheimer diseaseuridylate
项目摘要
PROJECT SUMMARY
Mitochondrial dysfunction is an early prominent feature in susceptible neurons in the brain of patients with
Alzheimer's disease (AD), which likely plays a critical role in the pathogenesis of AD. Mitochondria are dynamic
organelles that undergo continual fission and fusion events. Recent advances indicate that excessive
mitochondrial division (fission) is associated with functional defects and is implicated in multiple human diseases
including neurodegenerative diseases. Oxidative stress has been recognized as a contributing factor in aging
and in the progression of multiple neurodegenerative diseases including AD. Increased production of reactive
oxygen species (ROS) and disease-dependent loss of mitochondrial function are likely causally involved in loss
of hippocampal neuronal function in AD. However, molecular mechanisms underlying oxidative stress-induced
abnormal mitochondrial dynamics are yet to be determined. Mitochondrial dynamics and function may be
modulated by dysregulation of factors associated with mitochondrial fission. The major executor of fission is the
dynamin related protein 1 (DRP1), a mainly cytosolic protein which translocates to the mitochondrial surface in
order to mediate fission. Mff and Mid49/51 are mitochondrial membrane proteins that recruit DRP1 to the
mitochondria for fission. It is well established that expression of Mff and Mid49 are post-transcriptionally
regulated by specific miRNAs but it is not known why this regulation fails resulting in the increased mitochondrial
fission in AD. Importantly, our preliminary data demonstrated that in neuronal cells oxidative stress induce the
expression of ZCCHC6 which has been shown by us, and others, to uridylate miRNAs rendering them ineffective
in regulating gene expression. In our preliminary studies we also found mitochondrial network fragmentation in
N2a neurons with induced oxidative stress and that genes that regulate mitochondrial fission (Mff, Mid49) were
upregulated and miRNAs predicted to regulate their expression were downregulated. Therefore, our basic
hypothesis is that “Oxidative stress induced Zcchc6 in neurons contributes to AD pathogenesis by
rendering specific miRNAs that regulate mitochondrial fission factors ineffective by uridylation which
enhance mitochondrial fission and that inhibiting ZCCHC6 has the potential to inhibit and/or reverse
mitochondrial dysfunction in AD”. To test this hypothesis, we will characterize in detail the causal role of
aberrant ZCCHC6 expression in mediating oxidative stress-induced mitochondrial fragmentation in neurons in
vitro and the impact of in vivo depletion of Zcchc6 in two preclinical models on the development of AD and
cognitive impairment. Our findings will allow us to understand the biological and clinical relevance of oxidative
stress-induced upregulation of Zcchc6 and miRNA uridylation to regulate expression of signature genes
associated with mitochondrial impairment and fission in AD. Therefore, the results of our study would likely have
a major impact on AD research toward designing novel preventive and/or therapeutic strategies.
项目概要
线粒体功能障碍是患者大脑中易感神经元的一个早期显着特征
阿尔茨海默病 (AD) 线粒体是动态的,可能在 AD 的发病机制中发挥着关键作用。
经历持续裂变和融合事件的细胞器最近的进展表明过度。
线粒体分裂(裂变)与功能缺陷有关,并与多种人类疾病有关
包括神经退行性疾病,氧化应激已被认为是衰老的一个促成因素。
以及包括 AD 在内的多种神经退行性疾病的进展。
氧簇(ROS)和疾病依赖性线粒体功能丧失可能是导致线粒体功能丧失的原因
然而,氧化应激诱导的海马神经功能的分子机制。
异常的线粒体动力学尚未确定。线粒体动力学和功能可能尚未确定。
由与线粒体裂变相关的因子失调调节裂变的主要执行者是线粒体。
动力相关蛋白 1 (DRP1),一种主要的胞质蛋白,在线粒体中易位至线粒体表面
Mff 和 Mid49/51 是线粒体膜蛋白,可将 DRP1 募集到线粒体中。
众所周知,Mff 和 Mid49 的表达是转录后的。
受特定 miRNA 调节,但尚不清楚为什么这种调节失败导致线粒体增加
重要的是,我们的初步数据表明,在神经细胞中,氧化应激会诱导分裂。
我们和其他人已经证明 ZCCHC6 的表达可以使 miRNA 尿苷酸化,从而使其无效
在我们的初步研究中,我们还发现线粒体网络断裂。
具有诱导氧化应激的 N2a 神经元和调节线粒体裂变的基因(Mff、Mid49)
上调,而预测调节其表达的 miRNA 则下调。
假设是“神经元中氧化应激诱导的 Zcchc6 通过以下方式促进 AD 发病机制:
通过尿苷化使调节线粒体裂变因子的特定 miRNA 无效,
增强线粒体裂变,抑制 ZCCHC6 有可能抑制和/或逆转
AD 中的线粒体功能障碍”为了检验这一假设,我们将详细描述 AD 中线粒体功能障碍的因果作用。
ZCCHC6 表达异常介导神经元氧化应激诱导的线粒体碎片
两种临床前模型中 Zcchc6 的体外和体内耗竭对 AD 和 AD 发展的影响
我们的研究结果将使我们能够了解氧化的生物学和临床相关性。
应激诱导的 Zcchc6 上调和 miRNA 尿苷化调节特征基因的表达
因此,我们的研究结果可能与 AD 中的线粒体损伤和裂变有关。
对设计新颖的预防和/或治疗策略的 AD 研究产生重大影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tariq M Haqqi其他文献
Tariq M Haqqi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Tariq M Haqqi', 18)}}的其他基金
Uridylation of miRNAs by ZCCHC6 Regulates IL-6 Expression in Arthritis
ZCCHC6 对 miRNA 的尿苷化调节关节炎中 IL-6 的表达
- 批准号:
9041542 - 财政年份:2015
- 资助金额:
$ 75.14万 - 项目类别:
Identification of Plasma microRNA Expression Profile in Ankylosing Spondylitis.
强直性脊柱炎血浆 microRNA 表达谱的鉴定。
- 批准号:
8907904 - 财政年份:2014
- 资助金额:
$ 75.14万 - 项目类别:
Identification of Plasma microRNA Expression Profile in Ankylosing Spondylitis.
强直性脊柱炎血浆 microRNA 表达谱的鉴定。
- 批准号:
8770784 - 财政年份:2014
- 资助金额:
$ 75.14万 - 项目类别:
Suppression of MMP-13 Expression in Arthritis by Pomegranate
石榴抑制关节炎中 MMP-13 的表达
- 批准号:
8511347 - 财政年份:2013
- 资助金额:
$ 75.14万 - 项目类别:
Suppression of SHH Expression in Arthritis by Butea monosperma
紫矿对关节炎中 SHH 表达的抑制
- 批准号:
8737170 - 财政年份:2013
- 资助金额:
$ 75.14万 - 项目类别:
Suppression of MMP-13 Expression in Arthritis by Pomegranate
石榴抑制关节炎中 MMP-13 的表达
- 批准号:
8626484 - 财政年份:2013
- 资助金额:
$ 75.14万 - 项目类别:
Suppression of MMP-13 Expression in Arthritis by Pomegranate
石榴抑制关节炎中 MMP-13 的表达
- 批准号:
8706048 - 财政年份:2013
- 资助金额:
$ 75.14万 - 项目类别:
Suppression of SHH Expression in Arthritis by Butea monosperma
紫矿对关节炎中 SHH 表达的抑制
- 批准号:
8916552 - 财政年份:2013
- 资助金额:
$ 75.14万 - 项目类别:
Suppression of SHH Expression in Arthritis by Butea monosperma
紫矿对关节炎中 SHH 表达的抑制
- 批准号:
8508108 - 财政年份:2013
- 资助金额:
$ 75.14万 - 项目类别:
Suppression of SHH Expression in Arthritis by Butea monosperma
紫矿对关节炎中 SHH 表达的抑制
- 批准号:
9330067 - 财政年份:2013
- 资助金额:
$ 75.14万 - 项目类别:
相似海外基金
The mechanism of CELF1 upregulation and its role in the pathogenesis of Myotonic Dystrophy Type 1
CELF1上调机制及其在强直性肌营养不良1型发病机制中的作用
- 批准号:
10752274 - 财政年份:2024
- 资助金额:
$ 75.14万 - 项目类别:
Understanding resistance mechanisms to protein arginine methyltransransferase Inhibitors in Lymphoma
了解淋巴瘤对蛋白精氨酸甲基转移酶抑制剂的耐药机制
- 批准号:
10668754 - 财政年份:2023
- 资助金额:
$ 75.14万 - 项目类别:
Vector engineering for non-viral delivery of large genomic DNA to the RPE
用于将大基因组 DNA 非病毒传递至 RPE 的载体工程
- 批准号:
10667049 - 财政年份:2023
- 资助金额:
$ 75.14万 - 项目类别:
CRISPR-Cas Editing as a Genetic Cure for Autosomal Dominant Polycystic Kidney Disease
CRISPR-Cas 编辑作为常染色体显性多囊肾病的基因治疗
- 批准号:
10822502 - 财政年份:2023
- 资助金额:
$ 75.14万 - 项目类别:
Development of a novel site-and cell-selective mRNA therapeutic to treat atherosclerosis
开发一种新的位点和细胞选择性 mRNA 治疗剂来治疗动脉粥样硬化
- 批准号:
10679992 - 财政年份:2023
- 资助金额:
$ 75.14万 - 项目类别: